期刊文献+

高氧诱导新生鼠肺纤维化中CDK2及P27的表达和意义 被引量:2

Expression of CDK2 and P27 in Neonatal Rats with Hyperoxia-induced Chronic Lung Disease
下载PDF
导出
摘要 目的探讨细胞周期依赖蛋白激酶2(CDK2)及细胞周期蛋白依赖激酶抑制因子(P27)在高氧致慢性肺疾病(CLD)新生鼠肺纤维化中的动态表达规律及作用。方法采用高浓度氧诱导新生鼠CLD模型,应用免疫组织化学法、实时定量PCR法及Western blot技术,检测肺组织CDK2及P27蛋白和基因的表达,并同时测定肺组织纤维化评分。结果与对照组相比,实验组14、21dCDK2蛋白和基因的表达明显升高(P<0.05),P27的表达明显降低(P<0.05)。CDK2的动态表达变化与纤维化程度呈正相关(r=0.702),P27与纤维化程度呈负相关(r=-0.765)(P<0.05)。结论 CDK2及P27的异常表达与高氧致CLD肺纤维化密切相关。 Objective To investigate the expression and role of cyclin-dependent kinase-2(CDK2)and cyclin-dependent kinase inhibitors (P27)in pulmonary fibrosis in neonatal rats with hyperoxia-induced chronic lung disease (CLD).Methods CLD model was induced by hyperoxia exposure.The expression of CDK2 and P27 protein and mRNA were detected by immunohistochemiscal method,Real-time PCR and Western blot.Results Compared with the control group,the expression level of CDK2 protein and mRNA were increased significantly (P 〈 0.05)on day 14 and 21,while the expression of P27 were decreased significantly (P 〈 0.05).The dynamic expression of CDK2 was positively correlated with the degree of lung fibrosis,and the dynamic expression of P27 was negatively correlated with the degree of lung fibrosis.Conclusion The abnormal expression of CDK2 and P27 were related to pulmonary fibrosis in neonatal rats.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2010年第10期798-802,共5页 Journal of China Medical University
基金 国家自然科学基金资助项目(30872781)
关键词 细胞周期蛋白依赖性激酶2 细胞周期蛋白依赖性激酶抑制因子27 高氧 新生鼠 cyclin-dependent kinase-2; cyclin-dependent kinase inhibitors-27; hyperoxia; neonatal rat;
  • 相关文献

参考文献15

  • 1胡逸林,张端莲.CDK2蛋白在胆管细胞癌中的表达及临床意义[J].华南国防医学杂志,2010,24(1):3-5. 被引量:2
  • 2郑安锡,霍钢,黄晓明,唐文华,袁晓东,陈世平.细胞周期相关蛋白cyclin E、cdk2和p27^(kip1)在垂体腺瘤中的表达[J].现代医学,2009,37(3):179-183. 被引量:2
  • 3孙剑,陶立坚,宁旺斌,金鸥,刘纪实.p27和TGF-β在大鼠肾间质纤维化中的表达及关系[J].细胞与分子免疫学杂志,2008,24(8):808-810. 被引量:7
  • 4富建华,薛辛东.慢性肺疾病早产鼠转化生长因子β_1基因和蛋白动态表达及其对肺发育的抑制作用[J].中华儿科杂志,2005,43(6):463-465. 被引量:9
  • 5Sugatani J,Osabe M,Kurosawa M,et al.Induction of UGT1A1and CYP2B6by an antimitogenic factor in HepG2cells is mediated through suppression of cyclin-dependent kinase2activity:cell cycle-dependent expression. Drug Metabolism and Disposition . 2010
  • 6Lee CT,Lee YJ,Kwon SY,et al.In vivo imaging of adenovirus lransduction and enhanced therapeutic effieacy of combination therapy with conditionally replicating adenovirus and adenovims-p27. Cancer Research . 2006
  • 7Schuliga MJ,See I,Ong SC,et al.Fibrillar collagen clamps lung mesenchymal cells in a nonproliferative and noncontractile pheno-type. J Respir Cell Mol Biol . 2009
  • 8Ivetac A,McCammon J A.Elucidating the Inhibition Mechanism of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors through Multicopy Molecular Dynamics simulations. Journal of Molecular Biology . 2009
  • 9Corsino PE,Davis BJ,Norgaard PH,Parker NN,Law M,Dunn W,Law BK, et al.Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component. Neoplasia . 2008
  • 10Ashcroft T,Simpson JM,Timbrell V.Simple method of estimating severity of pulmonary fibrosis on a numerical scale. Journal of Clinical Pathology . 1988

二级参考文献34

  • 1张建国,王惠民,国华,郝天智,杨文军.NF-κB靶向性哑铃形圈套寡核苷酸抑制肾小球系膜细胞TGF-β_1的表达[J].第四军医大学学报,2004,25(14):1266-1269. 被引量:4
  • 2YELü,ZHANGHong-ying,WANGHua,YANGGuang-hua,BUHong,ZHANGLi,WANGShou-li.Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD[J].Chinese Medical Journal,2005(8):678-686. 被引量:7
  • 3任祖渊.垂体腺瘤诊断和治疗现状[J].中国神经肿瘤杂志,2006,4(1):1-4. 被引量:9
  • 4Nagino M, Kamiya J, Nishio H,et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up[J]. Ann Surg, 2006,243 (3) : 364-372.
  • 5Blechacz B, Gores GJ. Cholangiocarcinoma[J]. Clin Liver Dis, 2008,12(1) : 131-150.
  • 6Shaib YH, Davila JA, McGlynn K,et al. Rising incidence of intrahepatie cholangiocarcinoma in the United States: a true in crease? [J].J Hepatol,2004,40(3) :472-477.
  • 7Mouzas IA, Dimoulios P, Vlachonikolis IG, et al. Increasing incidence of cholangiocareinoma in C rete 1992- 2000 [J]. Anticancer Res,2002,22(6B):3637- 3641.
  • 8Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma:recent progress. Part 1 : epidemiology and etiology [J]. J Gastroenterol Hepatol,2002,17(10) : 1049-1055.
  • 9Bahar I,Chennubhotla C, Tobi D. Intrinsic dynamics of enzymes in the unbound state and relation to allosteric regulation[J].Curr Opin Struet Biol, 2007,17 (6) : 633-640.
  • 10Lange OF, Lakomek NA, Fare C, et al. Recognition dynamics up to microseconds revealed from an RDC-derived ubiquitin ensemble in solution[J].Science, 2008,320 (5882) : 1471 - 1475.

共引文献16

同被引文献9

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部